SARS-CoV-2-IN-34
SARS-CoV-2-IN-34 (S-20-1) is a blood brain barrier penetrable pan-coronavirus (CoV) fusion inhibitor with broad-spectrum inhibitory activity. SARS-CoV-2-IN-34 effectively inhibits infection by pseudotyped and authentic SARS-CoV-2, and pseudotyped variants of concern (VOCs) . SARS-CoV-2-IN-34 shows high affinity to RBD in S1 and HR1 domain in S2 of SARS-CoV-2 S protein. SARS-CoV-2-IN-34 can be used for the research of infection[1].
Product Specifications
CAS Number
3029103-37-2
UNSPSC
12352209
Target
SARS-CoV
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-34.html
Solubility
10 mM in DMSO
Smiles
CC(C[C@H]1CN(CC(N[C@H](CN(CC(N[C@H](CN(C(CCSCC2=CC=C(C(N[C@H](CN(CC(N1)=O)C(CCCN)=O)CC3=CC=CC=C3)=O)C=C2)=O)CC(NCCC(N[C@H](CN(C(CCC(O)=O)=O)CC(N)=O)CCC(O)=O)=O)=O)CC4=CC=CC=C4)=O)C(CC5=CC=C6C=CC=CC6=C5)=O)CC7=CC=CC=C7)=O)C(CCC8CCCCC8)=O)C
Molecular Formula
C91H119N13O16S
Molecular Weight
1683.06
References & Citations
[1]Xue S, et al. A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike protein. Cell Discov. 2022 Sep 8;8 (1) :88.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV649744 1.0 µg DNA
Evi2a Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details GTR10312850 96 Well
Porcine Ankyrin repeat and fibronectin type III domain containing protein 1 (ANKFN1) ELISA Kit
Sign In for Pricing
View Details